Joel M Reid, PhD

  • 7477 Citations
  • 44 Scopus h-Index
1976 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

  • 7477 Citations
  • 44 Scopus h-Index
  • 171 Article
  • 1 Comment/debate
Filter
Article

6-Aminonicotinamide sensitizes human tumor cell lines to cisplatin

Budihardjo, I. I., Walker, D. L., Svingen, P. A., Buckwalter, C. A., Desnoyers, S., Eckdahl, S., Shah, G. M., Poirier, G. G., Reid, J. M., Ames, M. M. & Kaufmann, S. H., Jan 1998, In : Clinical Cancer Research. 4, 1, p. 117-130 14 p.

Research output: Contribution to journalArticle

41 Scopus citations

Activation of the antitumor agent aminoflavone (NSC 686288) is mediated by induction of tumor cell cytochrome P450 1A1/1A2

Kuffel, M. J., Schroeder, J. C., Pobst, L. J., Naylor, S., Reid, J. M., Kaufmann, S. H. & Ames, M. M., 2002, In : Molecular Pharmacology. 62, 1, p. 143-153 11 p.

Research output: Contribution to journalArticle

55 Scopus citations

A limited sample model to predict area under the drug concentration curve for 17-(allylamino)-17-demethoxygeldanamycin and its active metabolite 17-(amino)-17-demethoxygeldanomycin

Furth, A. F., Mandrekar, S. J., Tan, A. D., Rau, A., Felten, S. J., Ames, M. M., Adjei, A., Erlichman, C. & Reid, J. M., Jan 2008, In : Cancer Chemotherapy and Pharmacology. 61, 1, p. 39-45 7 p.

Research output: Contribution to journalArticle

2 Scopus citations

Anastrozole Aromatase Inhibitor Plasma Drug Concentration Genome-Wide Association Study: Functional Epistatic Interaction Between SLC38A7 and ALPPL2

Dudenkov, T. M., Liu, D., Cairns, J., Devarajan, S., Zhuang, Y., Ingle, J. N., Buzdar, A. U., Robson, M. E., Kubo, M., Batzler, A., Barman, P., Jenkins, G. D., Carlson, E. E., Goetz, M. P., Northfelt, D. W., Moreno Aspitia, A., Desta, Z., Reid, J. M., Kalari, K. R., Wang, L. M. & 1 others, Weinshilboum, R. M., Jan 1 2019, In : Clinical pharmacology and therapeutics.

Research output: Contribution to journalArticle

Open Access
1 Scopus citations
96 Scopus citations

Antibody-targeted chemotherapy for the treatment of melanoma

Nevala, W. K., Buhrow, S. A., Knauer, D. J., Reid, J. M., Atanasova, E. A. & Markovic, S. N., Jul 1 2016, In : Cancer Research. 76, 13, p. 3954-3964 11 p.

Research output: Contribution to journalArticle

9 Scopus citations

A pediatric phase 1 trial of vorinostat and temozolomide in relapsed or refractory primary brain or spinal cord tumors: A children's oncology group phase 1 consortium study

Hummel, T. R., Wagner, L., Ahern, C., Fouladi, M., Reid, J. M., Mcgovern, R. M., Ames, M. M., Gilbertson, R. J., Horton, T., Ingle, A. M., Weigel, B. & Blaney, S. M., Sep 2013, In : Pediatric Blood and Cancer. 60, 9, p. 1452-1457 6 p.

Research output: Contribution to journalArticle

32 Scopus citations

A phase 1 and pharmacokinetic clinical trial of paclitaxel for the treatment of refractory leukemia in children: A Children's Oncology Group Study

Horton, T. M., Arnes, M. M., Reid, J. M., Krailo, M. D., Pendergrass, T., Mosher, R., Reaman, G. H. & Seibel, N. L., Apr 2008, In : Pediatric Blood and Cancer. 50, 4, p. 788-792 5 p.

Research output: Contribution to journalArticle

12 Scopus citations

A phase 1 dosing study of ruxolitinib in children with relapsed or refractory solid tumors, leukemias, or myeloproliferative neoplasms: A Children's Oncology Group phase 1 consortium study (ADVL1011)

Loh, M. L., Tasian, S. K., Rabin, K. R., Brown, P., Magoon, D., Reid, J. M., Chen, X., Ahern, C. H., Weigel, B. J. & Blaney, S. M., Oct 1 2015, In : Pediatric Blood and Cancer. 62, 10, p. 1717-1724 8 p.

Research output: Contribution to journalArticle

44 Scopus citations

A phase 1 study of cabozantinib in children and adolescents with recurrent or refractory solid tumors, including CNS tumors: Trial ADVL1211, a report from the Children's Oncology Group

Chuk, M. K., Widemann, B. C., Minard, C. G., Liu, X., Kim, A. R., Bernhardt, M. B., Kudgus, R. A., Reid, J. M., Voss, S. D., Blaney, S., Fox, E. & Weigel, B. J., Aug 1 2018, In : Pediatric Blood and Cancer. 65, 8, e27077.

Research output: Contribution to journalArticle

3 Scopus citations

A phase 1 study of eribulin mesylate (E7389), a novel microtubule-targeting chemotherapeutic agent, in children with refractory or recurrent solid tumors: A Children's Oncology Group Phase 1 Consortium study (ADVL1314)

Schafer, E. S., Rau, R. E., Berg, S., Liu, X., Minard, C. G., D'Adamo, D., Scott, R., Reyderman, L., Martinez, G., Devarajan, S., Reid, J. M., Fox, E., Weigel, B. J. & Blaney, S. M., Jan 1 2018, (Accepted/In press) In : Pediatric Blood and Cancer.

Research output: Contribution to journalArticle

5 Scopus citations

A phase 1 study of the c-Met inhibitor, tivantinib (ARQ197) in children with relapsed or refractory solid tumors: A Children's Oncology Group study phase 1 and pilot consortium trial (ADVL1111)

Geller, J. I., Perentesis, J. P., Liu, X., Minard, C. G., Kudgus, R. A., Reid, J. M., Fox, E., Blaney, S. M. & Weigel, B. J., Nov 1 2017, In : Pediatric Blood and Cancer. 64, 11, e26565.

Research output: Contribution to journalArticle

3 Scopus citations

A phase I and pharmacokinetic study of a powder-filled capsule formulation of oral irinotecan (CPT-11) given daily for 5 days every 3 weeks in patients with advanced solid tumors

Pilot, H. C., Adjei, A., Reid, J. M., Sloan, J. A., Atherton, P. J., Rubin, J., Alberts, S. R., Duncan, B. A., Denis, L., Schaaf, L. J., Yin, D., Sharma, A., McGovren, P., Miller, L. L. & Erlichman, C., Aug 2006, In : Cancer Chemotherapy and Pharmacology. 58, 2, p. 165-172 8 p.

Research output: Contribution to journalArticle

14 Scopus citations

A phase I and pharmacokinetic study of the selective, non-peptidic inhibitor of matrix metalloproteinase BAY 12-9566 in combination with etoposide and carboplatin

Molina, J. R., Reid, J. M., Erlichman, C., Sloan, J. A., Furth, A., Safgren, S. L., Lathia, C. D. & Alberts, S. R., Oct 2005, In : Anti-Cancer Drugs. 16, 9, p. 997-1002 6 p.

Research output: Contribution to journalArticle

21 Scopus citations

A phase I and pharmacologic study of pyrazoloacridine (NSC 366140) and carboplatin in patients with advanced cancer

Adjei, A., Reid, J. M., Erlichman, C., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Ruben, S., Boerner, S. A., Atherton, P., Ames, M. M. & Kaufmann, S. H., 2002, In : Investigational New Drugs. 20, 3, p. 297-304 8 p.

Research output: Contribution to journalArticle

6 Scopus citations
35 Scopus citations

A phase IB study of the pharmacokinetics of gemcitabine and pemetrexed, when administered in rapid sequence to patients with advanced solid tumors

Dy, G. K., Suri, A., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Atherton, P. J., Hanson, L. J., Burch, P. A., Rubin, J., Erlichman, C. & Adjei, A., Jun 2005, In : Cancer Chemotherapy and Pharmacology. 55, 6, p. 522-530 9 p.

Research output: Contribution to journalArticle

22 Scopus citations

A phase I clinical, pharmacological, and biological trial of interleukin 6 plus granulocyte-colony stimulating factor after ifosfamide, carboplatin, and etoposide in children with recurrent/refractory solid tumors: Enhanced hematological responses but a high incidence of grade III/IV constitutional toxicities

Bracho, F., Krailo, M. D., Shen, V., Bergeron, S., Davenport, V., Liu-Mares, W., Blazar, B. R., Panoskaltsis-Mortari, A., Van de Ven, C., Secola, R., Ames, M. M., Reid, J. M., Reaman, G. H. & Cairo, M. S., 2001, In : Clinical Cancer Research. 7, 1, p. 58-67 10 p.

Research output: Contribution to journalArticle

15 Scopus citations

A phase I clinical and pharmacokinetic study of CS-682 administered orally in advanced malignant solid tumors

Delaunoit, T., Burch, P. A., Reid, J. M., Camoriano, J. K., Kobayash, T., Braich, T. A., Kaur, J. S., Rubin, J. & Erlichman, C., Jul 2006, In : Investigational New Drugs. 24, 4, p. 327-333 7 p.

Research output: Contribution to journalArticle

15 Scopus citations

A phase i clinical trial of the Poly(ADP-ribose) polymerase inhibitor veliparib and weekly topotecan in patients with solid tumors

Wahner Hendrickson, A. E., Menefee, M. E., Hartmann, L. C., Long, H. J., Northfelt, D. W., Reid, J. M., Boakye-Agyeman, F., Kayode, O., Flatten, K. S., Harrell, M. I., Swisher, E. M., Poirer, G. G., Satele, D., Allred, J., Lensing, J. L., Chen, A., Ji, J., Zang, Y., Erlichman, C., Haluska, P. & 1 others, Kaufmann, S. H., Feb 15 2018, In : Clinical Cancer Research. 24, 4, p. 744-752 9 p.

Research output: Contribution to journalArticle

11 Scopus citations

A phase II study of alisertib in children with recurrent/refractory solid tumors or leukemia: Children's Oncology Group Phase I and pilot Consortium (ADVL0921)

Mosse, Y. P., Fox, E., Teachey, D. T., Reid, J. M., Safgren, S. L., Carol, H., Lock, R. B., Houghton, P. J., Smith, M. A., Hall, D., Barkauskas, D. A., Krailo, M., Voss, S. D., Berg, S. L., Blaney, S. M. & Weigel, B. J., Jun 1 2019, In : Clinical Cancer Research. 25, 11, p. 3229-3238 10 p.

Research output: Contribution to journalArticle

Open Access
5 Scopus citations

A phase I pharmacokinetic study of pulse-dose vorinostat with flavopiridol in solid tumors

Dickson, M. A., Rathkopf, D. E., Carvajal, R. D., Grant, S., Roberts, J. D., Reid, J. M., Ames, M. M., McGovern, R. M., Lefkowitz, R. A., Gonen, M., Cane, L. M., Dials, H. J. & Schwartz, G. K., Oct 2011, In : Investigational New Drugs. 29, 5, p. 1004-1012 9 p.

Research output: Contribution to journalArticle

25 Scopus citations

A phase I study of 17-allylaminogeldanamycin in relapsed/refractory pediatric patients with solid tumors: A children's oncology group study

Weigel, B. J., Blaney, S. M., Reid, J. M., Safgren, S. L., Bagatell, R., Kersey, J., Neglia, J. P., Ivy, S. P., Ingle, A. M., Whitesell, L., Gilbertson, R. J., Krailo, M., Ames, M. & Adamson, P. C., Mar 15 2007, In : Clinical Cancer Research. 13, 6, p. 1789-1793 5 p.

Research output: Contribution to journalArticle

71 Scopus citations

A Phase I study of bizelesin (NSC 615291) in patients with advanced solid tumors

Pitot, H. C., Reid, J. M., Sloan, J. A., Ames, M. M., Adjei, A., Rubin, J., Bagniewski, P. G., Atherton, P., Rayson, D., Goldberg, R. M. & Erlichman, C., 2002, In : Clinical Cancer Research. 8, 3, p. 712-717 6 p.

Research output: Contribution to journalArticle

28 Scopus citations

A phase I study of cixutumumab (IMC-A12) in combination with temsirolimus (CCI-779) in children with recurrent solid tumors: A Children's Oncology Group phase I consortium report

Fouladi, M., Perentesis, J. P., Wagner, L. M., Vinks, A. A., Reid, J. M., Ahern, C., Thomas, G., Mercer, C. A., Krueger, D. A., Houghton, P. J., Doyle, L. A., Chen, H., Weigel, B. & Blaney, S. M., Apr 1 2015, In : Clinical Cancer Research. 21, 7, p. 1558-1565 8 p.

Research output: Contribution to journalArticle

12 Scopus citations

A Phase i study of intermittently dosed vorinostat in combination with bortezomib in patients with advanced solid tumors

Deming, D. A., Ninan, J., Bailey, H. H., Kolesar, J. M., Eickhoff, J., Reid, J. M., Ames, M. M., McGovern, R. M., Alberti, D., Marnocha, R., Espinoza-Delgado, I., Wright, J., Wilding, G. & Schelman, W. R., 2014, In : Investigational New Drugs. 32, 2, p. 323-329 7 p.

Research output: Contribution to journalArticle

24 Scopus citations
1 Scopus citations

A phase i study of vorinostat in combination with bortezomib in patients with advanced malignancies

Schelman, W. R., Traynor, A. M., Holen, K. D., Kolesar, J. M., Attia, S., Hoang, T., Eickhoff, J., Jiang, Z., Alberti, D., Marnocha, R., Reid, J. M., Ames, M. M., McGovern, R. M., Espinoza-Delgado, I., Wright, J. J., Wilding, G. & Bailey, H. H., Dec 2013, In : Investigational New Drugs. 31, 6, p. 1539-1546 8 p.

Research output: Contribution to journalArticle

19 Scopus citations

A phase I trial and pharmacokinetic study of aflibercept (VEGF trap) in children with refractory solid tumors: A Children's Oncology Group phase I consortium report

Bender, J. G., Blaney, S. M., Borinstein, S., Reid, J. M., Baruchel, S., Ahern, C., Ingle, A. M., Yamashiro, D. J., Chen, A., Weigel, B., Adamson, P. C. & Park, J. R., Sep 15 2012, In : Clinical Cancer Research. 18, 18, p. 5081-5089 9 p.

Research output: Contribution to journalArticle

18 Scopus citations

A phase I trial of imetelstat in children with refractory or recurrent solid tumors: A children's oncology group phase I consortium study (ADVL1112)

Thompson, P. A., Drissi, R., Muscal, J. A., Panditharatna, E., Fouladi, M., Ingle, A. M., Ahern, C. H., Reid, J. M., Lin, T., Weigel, B. J. & Blaney, S. M., Dec 1 2013, In : Clinical Cancer Research. 19, 23, p. 6578-6584 7 p.

Research output: Contribution to journalArticle

30 Scopus citations

A phase I trial of ISIS 2503, an antisense inhibitor of H-ras, in combination with gemcitabine in patients with advanced cancer

Adjei, A., Dy, G. K., Erlichman, C., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P. J., Watanabe, T., Geary, R. S., Holmlund, J. & Dorr, F. A., Jan 1 2003, In : Clinical Cancer Research. 9, 1 I, p. 115-123 9 p.

Research output: Contribution to journalArticle

76 Scopus citations

A phase I trial of MK-2206 in children with refractory malignancies: A Children's Oncology Group study

Fouladi, M., Perentesis, J. P., Phillips, C. L., Leary, S., Reid, J. M., Mcgovern, R. M., Ingle, A. M., Ahern, C. H., Ames, M. M., Houghton, P., Doyle, L. A., Weigel, B. & Blaney, S. M., 2014, In : Pediatric Blood and Cancer. 61, 7, p. 1246-1251 6 p.

Research output: Contribution to journalArticle

30 Scopus citations

A phase I trial of the farnesyl protein transferase inhibitor R115777 in combination with gemcitabine and cisplatin in patients with advanced cancer

Adjei, A., Croghan, G. A., Erlichman, C., Marks, R. S., Reid, J. M., Sloan, J. A., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Bruzek, L. M., Atherton, P., Thibault, A., Palmer, P. A. & Kaufmann, S. H., Jul 1 2003, In : Clinical Cancer Research. 9, 7, p. 2520-2526 7 p.

Research output: Contribution to journalArticle

47 Scopus citations

A phase I trial of the novel farnesyl protein transferase inhibitor, BMS-214662, in combination with paclitaxel and carboplatin in patients with advanced cancer

Dy, G. K., Bruzek, L. M., Croghan, G. A., Mandrekar, S. J., Erlichman, C., Peethambaram, P., Pitot, H. C., Hanson, L. J., Reid, J. M., Furth, A., Cheng, S., Martell, R. E., Kaufmann, S. H. & Adjei, A., Mar 1 2005, In : Clinical Cancer Research. 11, 5, p. 1877-1883 7 p.

Research output: Contribution to journalArticle

31 Scopus citations

A phase I trial of twice-weekly 17-allylamino-demethoxy-geldanamycin in patients with advanced cancer

Nowakowski, G. S., McCollum, A. K., Ames, M. M., Mandrekar, S. J., Reid, J. M., Adjei, A., Toft, D. O., Safgren, S. L. & Erlichman, C., Oct 15 2006, In : Clinical Cancer Research. 12, 20 PART 1, p. 6087-6093 7 p.

Research output: Contribution to journalArticle

99 Scopus citations

A phase I trial of vorinostat and alvocidib in patients with relapsed, refractory, or poor prognosis acute leukemia, or refractory anemia with excess blasts-2

Holkova, B., Supko, J. G., Ames, M. M., Reid, J. M., Shapiro, G. I., Perkins, E. B., Ramakrishnan, V., Tombes, M. B., Honeycutt, C., McGovern, R. M., Kmieciak, M., Shrader, E., Wellons, M. D., Sankala, H., Doyle, A., Wright, J., Roberts, J. D. & Grant, S., Apr 1 2013, In : Clinical Cancer Research. 19, 7, p. 1873-1883 11 p.

Research output: Contribution to journalArticle

21 Scopus citations

A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: A Children's Oncology Group phase I consortium study (ADVL0916)

Muscal, J. A., Thompson, P. A., Horton, T. M., Ingle, A. M., Ahern, C. H., McGovern, R. M., Reid, J. M., Ames, M. M., Espinoza-Delgado, I., Weigel, B. J. & Blaney, S. M., Mar 2013, In : Pediatric Blood and Cancer. 60, 3, p. 390-395 6 p.

Research output: Contribution to journalArticle

42 Scopus citations

A randomized phase II and pharmacokinetic study of dacarbazine in patients with recurrent glioma

Rajkumar, S. V., Reid, J. M., Novotny, P. J., Safgren, S. L., Scheithauer, B. W., Johnson, S. P., Nair, S., Morton, R. F., Hatfield, A. K., Krook, J. E., Ames, M. M. & Buckner, J. C., 2000, In : Journal of Neuro-Oncology. 49, 3, p. 255-261 7 p.

Research output: Contribution to journalArticle

7 Scopus citations

A study of axitinib, a VEGF receptor tyrosine kinase inhibitor, in children and adolescents with recurrent or refractory solid tumors: A Children’s Oncology Group Phase 1 and Pilot Consortium Trial (ADVL1315)

Geller, J. I., Fox, E., Turpin, B. K., Goldstein, S. L., Liu, X., Minard, C. G., Kudgus, R. A., Reid, J. M., Berg, S. L. & Weigel, B. J., Jan 1 2018, (Accepted/In press) In : Cancer.

Research output: Contribution to journalArticle

3 Scopus citations

Author reply

Bakri, S. J., Reid, J. M., Snyder, M. R., Pulido, J. S. & Singh, R. J., Jan 2009, In : Ophthalmology. 116, 1, p. 169-170 2 p.

Research output: Contribution to journalArticle

CD38 Dictates Age-Related NAD Decline and Mitochondrial Dysfunction through an SIRT3-Dependent Mechanism

Camacho-Pereira, J., Tarragó, M. G., Chini, C. C. S., Nin, V., Escande, C., Warner, G. M., Puranik, A. S., Schoon, R. A., Reid, J. M., Galina, A. & Chini, E. N., Jun 14 2016, In : Cell Metabolism. 23, 6, p. 1127-1139 13 p.

Research output: Contribution to journalArticle

139 Scopus citations

Characterization of batracylin-induced renal and bladder toxicity in rats

Davis, M., Bunin, D. I., Samuelsson, S. J., Altera, K. P., Kinders, R. J., Lawrence, S. M., Ji, J., Ames, M. M., Buhrow, S. A., Walden, C., Reid, J. M., Rausch, L. L. & Parman, T., Jun 4 2015, In : Toxicologic Pathology. 43, 4, p. 519-529 11 p.

Research output: Contribution to journalArticle

3 Scopus citations

Chemoimmunotherapy reinduction with epratuzumab in children with acute lymphoblastic leukemia in marrow relapse: A children's oncology group pilot study

Raetz, E. A., Cairo, M. S., Borowitz, M. J., Blaney, S. M., Krailo, M. D., Leil, T. A., Reid, J. M., Goldenberg, D. M., Wegener, W. A., Carroll, W. L. & Adamson, P. C., 2008, In : Journal of Clinical Oncology. 26, 22, p. 3756-3762 7 p.

Research output: Contribution to journalArticle

162 Scopus citations

Clinical and pharmacokinetic studies of high-dose levamisole in combination with 5-fluorouracil in patients with advanced cancer

Reid, J. M., Kovach, J. S., O'Connell, M. J., Bagniewski, P. G. & Moertel, C. G., 1998, In : Cancer Chemotherapy and Pharmacology. 41, 6, p. 477-484 8 p.

Research output: Contribution to journalArticle

25 Scopus citations

Comparative bioavailability of sulindac in capsule and tablet formulations

Reid, J. M., Mandrekar, S. J., Carlson, E. C., Harmsen, W. S., Green, E. M., McGovern, R. M., Szabo, E., Ames, M. M., Boring, D. & Limburg, P. J., Mar 2008, In : Cancer Epidemiology Biomarkers and Prevention. 17, 3, p. 674-679 6 p.

Research output: Contribution to journalArticle

13 Scopus citations

Comparative pharmacokinetic study of continuous venous infusion fluorouracil and oral fluorouracil with eniluracil in patients with advanced solid tumors

Adjei, A., Reid, J. M., Diasio, R. B., Sloan, J. A., Smith, D. A., Rubin, J., Pitot, H. C., Alberts, S. R., Goldberg, R. M., Hanson, L. J., Atherton, P., Ames, M. M. & Erlichman, C., Mar 15 2002, In : Journal of Clinical Oncology. 20, 6, p. 1683-1691 9 p.

Research output: Contribution to journalArticle

27 Scopus citations

Comparative uterotrophic effects of endoxifen and tamoxifen in ovariectomized sprague-dawley rats

Schweikart, K. M., Eldridge, S. R., Safgren, S. L., Parman, T., Reid, J. M., Ames, M. M., Goetz, M. P. & Davis, M. A., Dec 29 2014, In : Toxicologic Pathology. 42, 8, p. 1188-1196 9 p.

Research output: Contribution to journalArticle

10 Scopus citations

Comparison of Bioavailability of Single-Dose Extended-Release Venlafaxine Capsules in Obese Patients Before and After Gastric Bypass Surgery

Krieger, C. A., Cunningham, J. L., Reid, J. M., Langman, L. J., Grothe, K., Clark, M. M. & Dierkhising, R. A., 2017, (Accepted/In press) In : Pharmacotherapy.

Research output: Contribution to journalArticle

6 Scopus citations

Comparison of idarubicin to daunomycin in a randomized multidrug treatment of childhood acute lymphoblastic leukemia at first bone marrow relapse: A report from the Children's Cancer Group

Feig, S. A., Ames, M. M., Sather, H. N., Steinherz, L., Reid, J. M., Trigg, M., Pendergrass, T. W., Warkentin, P., Gerber, M., Leonard, M., Bleyer, W. A. & Harris, R. E., Dec 1996, In : Medical and Pediatric Oncology. 27, 6, p. 505-514 10 p.

Research output: Contribution to journalArticle

32 Scopus citations

Controlled delivery of vancomycin via charged hydrogels

Gustafson, C. T., Boakye-Agyeman, F., Brinkman, C. L., Reid, J. M., Patel, R., Bajzer, Z., Dadsetan, M. & Yaszemski, M. J., Jan 1 2016, In : PLoS One. 11, 1, e0146401.

Research output: Contribution to journalArticle

16 Scopus citations